CD8A and neoplasm: The mechanisms underlying the suppressive effects of Tregs include inhibiting the activity of a variety of immune cells that are tumor specific such as CD4 and CD8 cells, B cells, NK cells, natural killer T cells (NKT), and DCs [19–21].